NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Capital Work in Progress | - | - | - | - | - |
What is the latest Capital Work in Progress ratio of NATH BIOGENES (INDIA) ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2013 | - |
How is Capital Work in Progress of NATH BIOGENES (INDIA) Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2013 | - | - | |
Compare Capital Work in Progress of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹296.8 Cr | -3.2% | -8.7% | -13.4% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,863.8 Cr | -3.9% | -9.4% | -25.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,000.7 Cr | -4.7% | -8.3% | 21.8% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,888.6 Cr | -0.7% | -7.8% | -20.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,156.9 Cr | -2.8% | -12.2% | -21.8% | Stock Analytics | |
| INDO US BIOTECH | ₹265.5 Cr | 9% | -2.9% | -55.9% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -3.2% |
-8.7% |
-13.4% |
| SENSEX | 0.5% |
1.7% |
11% |
You may also like the below Video Courses